PDF herunterladen
Thromb Haemost 1989; 62(02): 723-728
DOI: 10.1055/s-0038-1646891
Original Article
Schattauer GmbH Stuttgart

Plasminogen Activator Inhibitor 1: Biosynthesis and mRNA Level Are Increased by Insulin in Cultured Human Hepatocytes

T Kooistra
The Gaubius Institute TNO, Leiden, The Netherlands
,
P J Bosma
The Gaubius Institute TNO, Leiden, The Netherlands
,
H A M Töns
The Gaubius Institute TNO, Leiden, The Netherlands
,
A P van den Berg
The Gaubius Institute TNO, Leiden, The Netherlands
,
P Meyer
The Gaubius Institute TNO, Leiden, The Netherlands
,
H M G Princen
The Gaubius Institute TNO, Leiden, The Netherlands
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 07. März 1989

Accepted after revision 17. April 1989

Publikationsdatum:
30. Juni 2018 (online)

Auch verfügbar auf
  als PDF herunterladen  Lizenzen und Reprints

Summary

Clinical studies have shown that plasma insulin levels are closely related to plasma plasminogen activator inhibitor 1 (PAI-1) levels. To investigate a possible involvement of hepatocytes we have studied the effect of insulin on PAI-1 production by primary cultures of human hepatocytes. We have isolated human hepatocytes from seven left liver lobes. PAI-1 activity measured in 24 hours conditioned medium varied considerably between the various hepatocyte preparations (from 2.9 to 8.5 units per 5 cm2of cells) possibly as a result of interindividual variability in basal PAI-1 production by hepatocytes from different donors. In all cases, however, the relative extent, time profile and dose-dependency of the insulin-induced increase in PAI-1 synthesis were consistent. Up to about 7 nM, insulin dose-dependently increased both PAI-1 activity and PAI-1 antigen production. The increase in PAI-1 synthesis became measurable between 4 and 8 hours after addition of the hormone, and maximally reached twofold control values. The increase in PAI-1 synthesis could be fully explained by a concomitant increase in PAI-1 mRNA levels. The effect of insulin seems fairly specific for the synthesis of PAI-1: overall protein synthesis and mRNA levels of some control proteins (albumin and fibrinogen) did not markedly change after insulin addition. These results, obtained with primary cultures of human hepatocytes, are fully comparable with those obtained with the hepatocellular carcinoma cell line Hep G2. They strengthen the suggestion that the elevated level of PAI-1 in high insulin plasma might be the result of increased hepatic synthesis of PAI-1.

Keywords

Insulin - Plasminogen activator inhibitor 1 - Human hepatocytes - Hep G2
 

  • References

  • 1 Sprengers ED, Kluft C. Plasminogen activator inhibitors. Blood 1987; 69: 381-387
    PubMedGoogle Scholar
  • 2 Juhan-Vague I, Valadier J, Alessi MC, Aillaud MF, Ansaldi J, Philip-Joet C, Holvoet P, Serradimigni A, Collen D. Deficient t-PA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep venous thrombosis. Thromb Haemostas 1987; 57: 67-72
    PubMedGoogle Scholar
  • 3 Wiman B, Ljungberg B, Chmielewska J, Urden G, Blomback M, Johnsson H. The role of the fibrinolytic system in deep vein thrombosis. J Lab Clin Med 1985; 105: 265-270
    PubMedGoogle Scholar
  • 4 Nilsson IM, Ljungner H, Tengborn L. Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor. Br Med J 1985; 290: 1453-1456
    CrossrefPubMedGoogle Scholar
  • 5 Paramo JA, De Boer A, Colucci M, Jonker JJ C, Collen D. Plasminogen activator inhibitor (PA-inhibitor) activity in the blood of patients with deep vein thrombosis. Thromb Haemostas 1985; 54: 725
    PubMedGoogle Scholar
  • 6 Paramo JA, Colucci M, Collen D, Van de Werf F. Plasminogen activator inhibitor in the blood of patients with coronary artery disease. Br Med J 1985; 291: 573-574
    CrossrefPubMedGoogle Scholar
  • 7 Aillaud MF, Juhan-Vague I, Alessi MC, Marecal M, Vinson MF, Arnaud C, Vague P, Collen D. Increased PA-inhibitor levels in the post-operative period. No cause-effect relation with increased cortisol. Thromb Haemostas 1985; 54: 466-468
    PubMedGoogle Scholar
  • 8 Hamsten A, Wiman B, De Faire U, Blomback M. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med 1985; 313: 1557-1563
    CrossrefPubMedGoogle Scholar
  • 9 Vague P, Juhan-Vague I, Aillaud MF, Badier C, Viard R, Alessi MC, Collen D. Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects. Metabolism 1986; 35: 250-253
    CrossrefPubMedGoogle Scholar
  • 10 Juhan-Vague I, Vague P, Alessi MC, Badier C, Valadier J, Aillaud MF, Atlan C. Relationships between plasma insulin, triglyceride, body mass index, and plasminogen activator inhibitor 1. Diab Metabol 1987; 13: 331-336
    PubMedGoogle Scholar
  • 11 Alessi MC, Juhan-Vague I, Kooistra T, Declerck PJ, Collen D. Insulin stimulates the synthesis of plasminogen activator inhibitor 1 by hepatocellular cell line Hep G2. Tliromb Haemostas 1988; 60: 491-494
    PubMedGoogle Scholar
  • 12 Fair DS, Plow EF. Synthesis and secretion of the fibrinolytic components, including alpha2-antiplasmin, by a human hepatoma cell line. J Lab Clin Med 1983; 101: 372-384
    PubMedGoogle Scholar
  • 13 Knowles BB, Howe CC, Aden DP. Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science 1980; 209: 497-499
    CrossrefPubMedGoogle Scholar
  • 14 Levin EG, Fair DS, Loskutoff DJ. Human hepatoma cell line plasminogen activator. J Lab Clin Med 1983; 102: 500-508
    PubMedGoogle Scholar
  • 15 Zannis VI, Breslow JL, SanGiacomo TR, Aden DP, Knowles BB. Characterization of the major apolipoproteins secreted by two human hepatoma cell lines. Biochemistry 1981; 20: 7089-7096
    CrossrefPubMedGoogle Scholar
  • 16 Kluft C, Van Wezel AL, Van der Velden CAM, Emeis JJ, Verheijen JH, Wijngaards G. Large scale production of extrinsic (tissue-type) plasminogen activator from human melanoma cells. In: Advances in Biotechnological Processes. Mizrahi A, Van Wezel AL. (eds) AR Liss Inc; New York: 1983. (; 2). 97-110
    Google Scholar
  • 17 Gaffney PJ, Curtis AD. A collaborative study of a proposed international standard for tissue plasminogen activator (t-PA). Thromb Haemostas 1985; 53: 134-136
    PubMedGoogle Scholar
  • 18 Havekes L, Van Hinsbergh V, Kempen HJ, Emeis J. The metabolism in vitro of human low-density lipoprotein by the human hepatoma cell line Hep G2. Biochem J 1983; 214: 951-958
    CrossrefPubMedGoogle Scholar
  • 19 Sprengers ED, Princen HM G, Kooistra T, Van Hinsbergh VW M. Inhibition of plasminogen activators by conditioned medium of human hepatocytes and hepatoma cell line Hep G2. J Lab Clin Med 1985; 105: 751-758
    PubMedGoogle Scholar
  • 20 Princen HM G, Huijsmans CM G, Kuipers F, Vonk RJ, Kempen HJ M. Ketoconazole blocks bile acid synthesis in hepatocyte monolayer cultures and in vivo in rat by inhibiting cholesterol 7α-hydroxylase. J Clin Invest 1986; 78: 1064-1071
    CrossrefPubMedGoogle Scholar
  • 21 Havekes LM, Verboom H, De Wit E, Yap SH, Princen HM G. Regulation of low density lipoprotein receptor activity in primary cultures of human hepatocytes by serum lipoproteins. Hepatology 1986; 6: 1356-1360
    CrossrefPubMedGoogle Scholar
  • 22 Honn KV, Singley JA, Chavin W. Fetal bovine serum: a multivariate standard. Proc Soc Exp Biol Med 1975; 149: 344-347
    CrossrefPubMedGoogle Scholar
  • 23 Ballet F, Bouma ME, Wang SR, Amit N, Marais J, Infante R. Isolation, culture and characterization of adult human hepatocytes from surgical liver biopsies. Hepatology 1984; 4: 849-854
    CrossrefPubMedGoogle Scholar
  • 24 Guillouzo A, Beaunne P, Gascoin MN, Begue JM, Campion JP, Guengerich FP, Guguen-Guillouzo C. Maintenance of cytochrome P-450 in cultured adult human hepatocytes. Biochem Pharmacol 1985; 34: 2991-2995
    CrossrefPubMedGoogle Scholar
  • 25 Strom SC, Jirtle RL, Jones RS, Novicki DL, Rosenberg MR, Novotny A, Irons G, McLain JR, Michalopoulos G. Isolation, culture, and transplantation of human hepatocytes. J Natl Cancer Inst 1982; 68: 771-778
    PubMedGoogle Scholar
  • 26 Kosykh VA, Preobrazhensky SN, Ivanov VO, Tsibulsky VP, Repin VS, Smirnov VN. High-affinity association and degradation of 125I-labelled low density lipoproteins by human hepatocytes in primary culture. FEBS Lett 1985; 183: 17-20
    CrossrefPubMedGoogle Scholar
  • 27 Edge SB, Hoeg JM, Triche T, Schneider PD, Brewer HB. Cultured human hepatocytes. Evidence for metabolism of low density lipoproteins by a pathway independent of the classical low density lipoprotein receptor. J Biol Chem 1986; 261: 3800-3806
    PubMedGoogle Scholar
  • 28 Maekubo H, Ozaki S, Mitmaker B, Kalant N. Preparation of human hepatocytes for primary culture. In Vitro 1982; 18: 483-491
    CrossrefPubMedGoogle Scholar
  • 29 Castell JV, Gómez-Lechón MJ, David M, Hirano T, Kishimoto T, Heinrich PC. Recombinant human interleukin-6 (IL-6/BSF-2/HSF) regulates the synthesis of acute phase proteins in human hepatocytes. FEBS Lett 1988; 232: 347-350
    CrossrefPubMedGoogle Scholar
  • 30 Moshage HJ, Roelofs HM J, Van Pelt JF, Hazenberg BP C, Van Leeuwen MA, Limburg PC, Aarden LA, Yap SH. The effect of interleukin-1, interleukin-6 and its interrelationship on the synthesis of serum amyloid A and C-reactive protein in primary cultures of adult human hepatocytes. Biochem Biophys Res Commun 1988; 155: 112-117
    CrossrefPubMedGoogle Scholar
  • 31 Verheijen JH, Chang GT G, Kluft C. Evidence for the occurrence of a fast-acting inhibitor for tissue-type plasminogen activator in human plasma. Thromb Haemostas 1984; 51: 392-395
    PubMedGoogle Scholar
  • 32 Lowry OH, Rosebrough NJ, Farr A, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-275
    PubMedGoogle Scholar
  • 33 Wang CS, Smith RL. Lowry determination of protein in the presence of Triton X-100. Anal Biochem 1975; 63: 414-417
    CrossrefPubMedGoogle Scholar
  • 34 Lizardi PM, Engelberg A. Rapid isolation of RNA using proteinase K and sodium perchlorate. Anal Biochem 1979; 98: 116-122
    CrossrefPubMedGoogle Scholar
  • 35 Maniatis T, Fritsch EF, Sambrook J. Molecular Cloning; A Laboratory Manual. Cold Spring Harbor Laboratory. 1982. ISBN 0-87969136-0
    Google Scholar
  • 36 Church GM, Gilbert W. Genomic sequencing. Proc Natl Acad Sci USA 1984; 81: 1991-1995
    CrossrefPubMedGoogle Scholar
  • 37 Van den Berg EA, Sprengers ED, Jaye M, Burgess W, Maciag T, Van Hinsbergh VW M. Regulation of plasminogen activator inhibitor-1 mRNA in human endothelial cells. Thromb Haemostas 1988; 60: 63-67
    PubMedGoogle Scholar
  • 38 Dugaiczyk A, Law SW, Dennison OE. Nucleotide sequence and the encoded amino acids of human serum albumin mRNA. Proc Natl Acad Sci USA 1982; 79: 71-75
    CrossrefPubMedGoogle Scholar
  • 39 Lord ST. Expression of a cloned human fibrinogen cDNA in Escherichia coli: synthesis of an A alpha polypeptide. DNA 1985; 4: 33-38
    CrossrefPubMedGoogle Scholar
  • 40 Terpstra OT, Schalm SW, Weimar W, Willemse PJ A, Baumgartner D, Groenland TH N, Ten Kate FW J, Porte RJ, De Rave S, Reuvers CB, Stibbe J, Terpstra JL. Auxiliary partial liver transplantation for end-stage chronic liver disease. N Engl J Med 1988; 319: 1507-1511
    CrossrefPubMedGoogle Scholar
  • 41 Misbin RI, Merimee TJ, Lowenstein JM. Insulin removal by isolated perfused rat liver. Am J Physiol 1976; 230: 171-177
    PubMedGoogle Scholar
  • 42 Kooistra T, Sprengers ED, Van Hinsbergh VW M. Rapid inactivation of the plasminogen-activator inhibitor upon secretion from cultured human endothelial cells. Biochem J 1986; 239: 497-503
    CrossrefPubMedGoogle Scholar
  • 43 Emeis JJ, Kooistra T. Interleukin 1 and lipopolysaccharide induce an inhibitor of tissue-type plasminogen activator in vivo and in cultured endothelial cells. J Exp Med 1986; 163: 1260-1266
    CrossrefPubMedGoogle Scholar
  • 44 Van Hinsbergh VW M, Kooistra T, Van den Berg EA, Princen HM G, Fiers W, Emeis JJ. Tumor necrosis factor increases the production of plasminogen activator inhibitor in human endothelial cells in vitro and in rats in vivo. Blood 1988; 72: 1467-1473
    PubMedGoogle Scholar